Fig. S1
Tissue distribution of (2) (HCl salt) in mouse. Fluorescence micrographs of heart muscle (a-c), liver (d-f), kidney (g-i), lung (j-l), brain (m-o), spleen (p-r) tissue sections isolated from mice 20 min after ip injection. Exposure time: heart (14000 ms), liver (300 ms), kidney (500 ms), lung (1200 ms), brain (15000ms), and spleen (500 ms); λmax = 488 nm (green fluorescence from FITC).
Fig. S2
The body weight changes in experimental groups.
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Experimental section
General Synthetic Chemistry Methods. All non-hydrolytic reactions were carried out in ovendried glassware under an inert atmosphere of dry argon or nitrogen. All commercial chemicals were used as received except for solvents, which were purified and dried by standard methods prior to use. Analytical TLC was performed on a Merck 60 F254 silica gel plate (0.25mm thickness), analytical reverse-phase TLC on a Merck RP-8 F254s, and visualization was done with UV light (254nm and 365nm), or by spraying with a 5% solution of phosphomolybdic acid or ninhydrine solution followed by charring with a heat gun. Column chromatography was performed on Merck 60 silica gel (70-230 or 230-400 mesh), and MPLC was performed on Fluka 100 C 8 -reversed phase silica gel. NMR spectra were recorded on a Bruker DPX 300 ( Tissue Distribution Study. The transporter 2 (HCl salts, 115.6 mg/Kg) was dissolved in sterile distilled water (500 μL) and injected into 8-week-old mice (C57BL/6) intraperitoneally (i.p.).
1-O-{(benzyloxycarbonyl)-amino-hexanoyl}-2,3,4,5-tetra-O-{bis-[3-(N,N'-di-Boc-N''-aminopropylguanidine)-amino]-hexanoyl}-D-Sorbitol (4):
The treated mice were perfused after 20 minutes with 4 % paraformaldehyde in PBS (pH 7.4).
The organs were incubated overnight in 0.5 M sucrose in PBS. Placed in cryoprotectant, they were cut into 15-μm sections with cryostat, and transferred to coated glass slides. After drying at 37 °C, the sections were washed with PBS and treated with 0.3 % Triton X-100 for 15 minutes at room temperature and analyzed under an Axioplan2 fluorescence imaging microscope.
Cell culture and Reagents. U-87MG human GBM cells (ATCC) were grown in EMEM supplemented with 10% FBS, 2 mM L-glutamine, penicillin (100 units/mL), and streptomycin (100 μg/mL). 
Quantification of immunostaining.
For the quantification of immunostaining for PCNA and TUNEL assay, the number of stained cells was counted in ten random fields at x400 magnification. For the CD31 and ED1, the number of stained cells was counted in ten random fields at x200 magnification.
Statistical analyses.
Statistical comparisons between groups were performed using Student's ttest, one-way ANOVA or multiple comparison tests. P < 0.05 was considered statistically significant.
Toxicity test (MTT assay).
HeLa, COS-7, and RAW264.7 cells were cultured in each 96-well microplate respectively with Dulbecco's modification of Eagle's medium (DMEM) with 5% fetal bovine serum (FBS) in an initial density of 5x10 3 cells per well. They were maintained at dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 1 In this assay, cells that properly metabolize the MTT dye undergo a visible color change, while cells that are incapable of metabolizing the dye remain colorless. The culture medium was removed and replaced by 100 μL of the new culture medium containing 10% MTT reagent. The cells were then incubated for 4h at 37 °C to allow the formation of formazan dye. The medium containing 10% MTT reagent was replaced by DMSO, which was used to solubilize the formazan crystals. After aging for 10 min followed by centrifugation for 10 min, 80 μL from each well was transferred to a new plate for spectrophotometric measurements. The quantification of cell viability was performed using optical absorbance (540/690 nm) and an ELISA plate reader.
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